Senior insider sale
PRESIDENT AND CEO at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$90.4K
25.59K shares
What this filing means
AUERBACH ALAN H plans to sell 25.59K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $90.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/8/2025ACC: 0001959173-25-004506
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
25.59K
Shares to sell
$90.4K
Approx. market value
25.59K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
7/7/2025
25.59KTotal acquired25.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/7/2025 | Restricted Stock Vesting Compensation | 25.59K | — |
| Total | 25.59K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
25.59K
Market value
$90.4K
7/8/2025
Total
Units
25.59K
Value
$90.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/8/2025 | 25.59K | $90.4K | NASDAQ | Planned |
| Total | 25.59K | $90.4K | ||